Product Recalls in Montana

Product recalls affecting Montana — including food, drugs, consumer products, medical devices, and vehicles distributed to Montana. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,530 recalls have been distributed to Montana in the last 12 months.

48,326 total recalls
2,530 in last 12 months

Showing 72617280 of 13,407 recalls

DrugFebruary 13, 2018· Hetero Labs Limited Unit V

Recalled Item: Valacyclovir Tablets USP 1 gram Recalled by Hetero Labs Limited Unit V Due...

The Issue: Temperature Abuse: Valganciclovir Tablets USP 450 mg and Valacyclovir...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Amitriptyline HCl USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· Apace KY LLC

Recalled Item: Acyclovir Tablets Recalled by Apace KY LLC Due to Presence of Foreign...

The Issue: Presence of Foreign Tablet/Capsule; cartons labeled to contain Acyclovir...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Nifedipine USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Calcipotriene BP (Monohydrate) for prescription compounding Recalled by...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Testosterone Cypionate USP (Micronized) for prescription compounding...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Baclofen USP (Micronized) for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Cyclobenzaprine HCl USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Tadalafil USP (Monohydrate) for prescription compounding Recalled by...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Estradiol USP (Micronized) (Yam) for prescription compounding Recalled by...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Duloxetine HCl USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Sildenafil Citrate USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Tramadol HCl USP (CIV) for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Oxandrolone USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Estradiol Hemihydrate USP (Micronized) (Soy) for prescription compounding...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Phentolamine Mesylate USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Prilocaine HCl USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Levetiracetam USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Doxycycline Hyclate USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugFebruary 9, 2018· American Pharmaceutical Ingredients LLC

Recalled Item: Verapamil HCl USP for prescription compounding Recalled by American...

The Issue: CGMP Deviations: Lack of stability data and controls to support the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund